National Health Investors (NYSE:NHI) Updates FY 2025 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 4.680-4.730 for the period, compared to the consensus earnings per share estimate of 4.650. The company issued revenue guidance of -.

National Health Investors Stock Performance

National Health Investors stock traded up $1.67 during mid-day trading on Tuesday, hitting $77.71. 12,210 shares of the company’s stock traded hands, compared to its average volume of 222,098. The firm has a 50 day simple moving average of $73.77 and a two-hundred day simple moving average of $72.72. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The stock has a market cap of $3.63 billion, a price-to-earnings ratio of 26.29, a P/E/G ratio of 4.42 and a beta of 0.78. National Health Investors has a fifty-two week low of $63.91 and a fifty-two week high of $86.13.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $68.87 million during the quarter, compared to analysts’ expectations of $85.13 million. During the same period in the previous year, the company posted $1.10 earnings per share. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, research analysts expect that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 2nd. Stockholders of record on Monday, March 31st were paid a $0.90 dividend. The ex-dividend date of this dividend was Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.63%. National Health Investors’s payout ratio is currently 115.38%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of research reports. Truist Financial boosted their target price on shares of National Health Investors from $70.00 to $76.00 and gave the stock a “hold” rating in a report on Wednesday, March 19th. Wedbush restated an “outperform” rating and set a $88.00 price objective on shares of National Health Investors in a research note on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $85.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.